ID

34385

Descrizione

Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy; ODM derived from: https://clinicaltrials.gov/show/NCT00861172

collegamento

https://clinicaltrials.gov/show/NCT00861172

Keywords

  1. 17/01/19 17/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

17 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Lesions NCT00861172

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 18 and 50 years.
Descrizione

ID.1

Tipo di dati

boolean

health coverage.
Descrizione

ID.2

Tipo di dati

boolean

any form of ms defined by mc donald's criteria (2005).
Descrizione

ID.3

Tipo di dati

boolean

patients having shown an enhanced plaque on a less than six month mri examination.
Descrizione

ID.4

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
Descrizione

ID.5

Tipo di dati

boolean

cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
Descrizione

ID.6

Tipo di dati

boolean

patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
Descrizione

ID.7

Tipo di dati

boolean

pregnancy or pregnancy desire.
Descrizione

ID.8

Tipo di dati

boolean

patient with a low creatinine clearance <60 ml/mn
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 18 and 50 years.
boolean
ID.2
Item
health coverage.
boolean
ID.3
Item
any form of ms defined by mc donald's criteria (2005).
boolean
ID.4
Item
patients having shown an enhanced plaque on a less than six month mri examination.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
boolean
ID.6
Item
cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
boolean
ID.7
Item
patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
boolean
ID.8
Item
pregnancy or pregnancy desire.
boolean
ID.9
Item
patient with a low creatinine clearance <60 ml/mn
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial